HIGHLIGHTS
- who: Chengfu Wu and collaborators from the Ophthalmology Department, Affiliated Hospital of Panzhihua University, Panzhihua, Sichuan, China have published the paper: Exploring the Mechanism of Curcumin on Retinoblastoma Based on Network Pharmacology and Molecular Docking, in the Journal: Evidence-Based Complementary and Alternative Medicine of 19/07/2022
- what: This study explored the potential therapeutic targets and pharmacological mechanisms of curcumin against retinoblastoma based on network pharmacology and molecular docking. This study provides a basis for further experimental studies and ideas to investigate the mechanism of curcumin in the treatment of retinoblastoma, and further studies . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.